Healthcare
Apposite's Riverdale Healthcare bolts on dental practises
Combined businesses will offer a greater range of private and specialist treatments
Palatine impact fund backs Veincentre
Clinic operator focusing on varicose vein treatments will open new sites in Glasgow and Leeds
Nordic Capital shelves GHD GesundHeits sale - report
Nordic Capital has halted a sale process for homecare company GHD, which involved PAI and CD&R
EQT to sell Charleston
EQT acquired Charleston in 2014 and made nine bolt-on acquisitions throughout its holding period
Waterland sells HistoGeneX to PE-backed Caprion Biosciences
Waterland exits Belgium-based biotechnology business HistoGeneX to Canadian peer Caprion
LSP et al. in €67m series-A for Alizé Pharma 3
LSP leads the round for the biotech business, investing alongside previous and new backers
Waterland inks first deal in Ireland
Dutch GP previously backed senior residential care operators based across Europe
Gimv's AgroSavfe receives €35m from investor consortium
Corporate Ackermans & van Haaren is backing AgroSavfe for the first time, injecting €10m
VC-backed Predictimmune raises £10m series-B
BGF joins existing investors in the UK biotech firm with a ТЃ4m equity contribution
BtoV, Wellington and Seroba co-lead $48m series-C for Quanta
Existing investors BtoV, Wellington and Seroba all invested in the company's series-A in 2009
Ardian sells Ionisos
Latest transaction is France-based Ionisos's fifth buyout transaction since Acto bought it in 2004
Naxicap, Ardian back Emera MBO
GPs will help France-based Emera, a residential care home service, to expand abroad
Gimv, Sofinnova, Gilde exit Breath Therapeutics for €500m
Gimv and Sofinnova Partners co-led a 2017 €43.5m series-A for Breath Therapeutics, with participation from Gilde Helathcare
Vespa invests £17m in Bluecrest buyout
GP is currently investing from its second fund, which typically invests in firms with ТЃ10-70m enterprise value
Innova buys Optiplaza
GP draws capital from Innova 6, a fund with a target of €325m that held a first close on €196m
Cairngorm acquires Millbrook Healthcare
Mobility equipment company will form the basis for a buy-and-build programme in the assisted living space
Waterland's Median Kliniken bolts on Eschenburg, Rhein-Reha
Waterland has owned Median Kliniken since 2014 and has now bolted on 21 companies
Keensight carves out 3P Biopharmaceuticals
GP backs biologics production service 3P Biopharmaceuticals via Keensight Capital V
Paragon acquires Pro Optik
Optical retail chain Pro Optik is likely to be Paragon III fund's first acquisition
Sunstone backs Forendo Pharma
Fresh capital will be used to advance its endometriosis programme into the next phase
Permira acquires Quotient from GHO for a reported £600m
Outsourced drug development company has expanded into the US and tripled its revenues under GHO
Medicxi closes third fund on €400m
Vehicle will invest across the full spectrum of healthcare companies from early to late stages
LSP, Andera et al. invest €116m in AM-Pharma
Forbion, Ysios Capital and Idinvest also back the financing for the biopharmaceutical company
VCs sell Amal to Boehringer Ingelheim in €325m deal
Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds provided seed funding for Amal in 2014